Amgen (AMGN) Tops Q4 EPS by 42c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $402.98 -0.01%
EPS Growth %: +2.7%
Financial Fact:
Selling, general and administrative: 1.24B
Today's EPS Names:
VFS, PKE, More
EPS Growth %: +2.7%
Financial Fact:
Selling, general and administrative: 1.24B
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $3.81, $0.42 better than the analyst estimate of $3.39. Revenue for the quarter came in at $6.6 billion versus the consensus estimate of $6.58 billion.
GUIDANCE:
Amgen sees FY2021 EPS of $16.00-$17.00, versus the consensus of $17.02. Amgen sees FY2021 revenue of $25.8-26.6 billion, versus the consensus of $26.43 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
- Lucid Group reports Q3 2026 production and delivery figures
- ConAgra Brands (CAG) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
